Poly(vinyl alcohol)-coated silver nanoparticles: Activation of neutrophils and nanotoxicology effects in human hepatocarcinoma and mononuclear cells

Environmental Toxicology and Pharmacology - Tập 39 - Trang 614-621 - 2015
Iêda Maria Martinez Paino1, Valtencir Zucolotto1
1Nanomedicine and Nanotoxicology Group, Physics Institute of São Carlos, University of São Paulo, Av. Trab. São Carlense, 400, CEP13566-590 São Carlos, SP, Brazil

Tài liệu tham khảo

Avalos, 2014, Interactions of manufactured silver nanoparticles of different sizes with normal human dermal fibroblasts, Int. Wound J., 25 Avalos, 2014, Cytotoxicity and ROS production of manufactured silver nanoparticles of different sizes in hepatoma and leukemia cells, J. Appl. Toxicol., 34, 413, 10.1002/jat.2957 Asharani, 2009, Cytotoxicity and genotoxicity of silver nanoparticles in human cells, ACS Nano, 3, 279, 10.1021/nn800596w Bass, 1986, Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection, J. lmmunol., 136, 860 Burow, 1987, Flow-cytometric characterization of stimulation, free radical formation, peroxidase activity and phagocytosis of human granulocytes with 2.7-dichlorofluorescein (DCF), Eur. J. Cell Biol., 43, 128 Cancino, 2013, In vitro nanotoxicity of single-walled carbon nanotube-dendrimer nanocomplexes against murine myoblast cells, Toxicol. Lett., 10, 18, 10.1016/j.toxlet.2013.02.009 Chithrani, 2006, Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells, Nano Lett., 6, 662, 10.1021/nl052396o Choi, 2008, Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells, Cancer Lett., 261, 37, 10.1016/j.canlet.2007.11.014 Clark, 1999, Activation of the neutrophil respiratory burst oxidase, J. Infect. Dis., 179, 309, 10.1086/513849 Fatisson, 2012, Physicochemical characterization of engineered nanoparticles under physiological conditions: effect of culture media components and particle surface coating, Colloids Surf. B-Biointerfaces, 91, 198, 10.1016/j.colsurfb.2011.10.056 Flower, 2012, Characterization of synthesized silver nanoparticles and assessment of its genotoxicity potentials using the alkaline comet assay, Mutat. Res., 742, 61, 10.1016/j.mrgentox.2011.12.003 Foldbjerg, 2009, PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes, Toxicol. Lett., 190, 156, 10.1016/j.toxlet.2009.07.009 Gaiser, 2013, Effects of silver nanoparticles on the liver and hepatocytes in vitro, Toxicol. Sci., 131, 537, 10.1093/toxsci/kfs306 Greulich, 2011, Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles, Acta Biomater., 7, 3505, 10.1016/j.actbio.2011.05.030 Haase, 2012, Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses, Toxicol. Sci., 126, 457, 10.1093/toxsci/kfs003 Haberl, 2013, Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats, Beilstein J. Nanotechnol., 19, 933, 10.3762/bjnano.4.105 Johnston, 2010, A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity, Crit. Rev. Toxicol., 40, 328, 10.3109/10408440903453074 Kawata, 2009, In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells, Environ. Sci. Technol., 43, 6046, 10.1021/es900754q Kim, 2009, Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells, Toxicol in Vitro, 23, 1076, 10.1016/j.tiv.2009.06.001 Lewinski, 2008, Small, 4, 26, 10.1002/smll.200700595 Mammucari, 2010, Signaling pathways in mitochondrial dysfunction and aging, Mech. Ageing Dev., 131, 536, 10.1016/j.mad.2010.07.003 Marano, 2011, Nanoparticles: molecular targets and cell signalling, Arch. Toxicol., 85, 733, 10.1007/s00204-010-0546-4 Oberdörster, 2005, Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles, Environ. Health Perspect., 113, 823, 10.1289/ehp.7339 Paino, 2012, Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells, Toxicol. Lett., 30, 119, 10.1016/j.toxlet.2012.09.025 Paino, 2009, Phagocytosis, oxidative burst and produced reactive species are affected by iron deficiency anemia and anemia of chronic diseases in elderly, Biol. Trace Elem. Res., 129, 116, 10.1007/s12011-008-8303-8 Paino, 2005, Effect of therapeutic plasma concentrations of non-steroidal anti-inflammatory drugs on the production of reactive oxygen species by activated rat neutrophils, Braz. J. Med. Biol. Res., 38, 543, 10.1590/S0100-879X2005000400007 Shin, 2007, The effects of nanosilver on the proliferation and cytokine expression by peripheral blood mononuclear cells, Int. Immunopharmacol., 7, 1813, 10.1016/j.intimp.2007.08.025 Smith, 1993, Further characterization of the neutrophil oxidative burst by flow cytometry, J. Immunol. Methods, 162, 261, 10.1016/0022-1759(93)90391-J Singh, 2012, Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles, Toxicol. Lett., 213, 249, 10.1016/j.toxlet.2012.07.009 Singh, 1988, A simple technique for quantitation of low-levels of DNA damage in individual cells, Exp. Cell Res., 175, 184, 10.1016/0014-4827(88)90265-0 Sohaebuddin, 2010, Nanomaterial cytotoxicity is composition, size, and cell type dependent, Part Fibre Toxicol., 21, 7 Sonavane, 2008, Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size, Colloid Surf. B-Biointerfaces, 66, 274, 10.1016/j.colsurfb.2008.07.004 Suzuki, 2007, Simple and easy method to evaluate uptake potential of nanoparticles in mammalian cells using a flow cytometric light scatter analysis, Environ. Sci. Technol., 41, 3018, 10.1021/es0625632 Tang, 2009, Distribution, translocation and accumulation of silver nanoparticles in rats, J. Nanosci. Nanotechnol., 9, 4924, 10.1166/jnn.2009.1269 Vallhov, 2006, The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications, Nano Lett., 6, 1682, 10.1021/nl060860z